Publications at FLI

2023

• Leveraging quantum computing for dynamic analyses of logical networks in systems biology.
  Weidner FM, Schwab JD, Wölk S, Rupprecht F, Ikonomi N, Werle SD, Hoffmann S, Kühl M, Kestler HA
  PATTERNS 2023, 4(3), 100705
  

2022

• p53-mediated AKT and mTOR inhibition requires RFX7 and DDIT4 and depends on nutrient abundance.
  Coronel* L, Häckes* D, Schwab* K, Riege K, Hoffmann** S, Fischer** M
  Oncogene 2022, 41(7), 1063-9 * equal contribution, ** co-corresponding authors
  
• Synthesizing genome regulation data with vote-counting.
  Fischer M, Hoffmann S
  Trends Genet 2022, 38(12), 1208-16
  
• Coordinating gene expression during the cell cycle.
  Fischer M, Schade AE, Branigan TB, Müller GA, DeCaprio JA
  Trends Biochem Sci 2022, 47(12), 1009-22
  
• TargetGeneReg 2.0: a comprehensive web-atlas for p53, p63, and cell cycle-dependent gene regulation.
  Fischer* M, Schwarz R, Riege K, DeCaprio JA, Hoffmann S
  NAR Cancer 2022, 4(1), zcac009 * corresponding author
  
• LINC00892 Is an lncRNA Induced by T Cell Activation and Expressed by Follicular Lymphoma-Resident T Helper Cells.
  Iaccarino I, Mourtada F, Reinke S, Patil P, Doose G, Monaco G, Hoffmann S, Siebert R, Klapper W
  Noncoding RNA 2022, 8(3)
  
• Taz protects hematopoietic stem cells from an aging-dependent decrease in PU.1 activity.
  Kim* KM, Mura-Meszaros* A, Tollot* M, Krishnan MS, Gründl M, Neubert L, Groth M, Rodriguez-Fraticelli A, Svendsen AF, Campaner S, Andreas N, Kamradt T, Hoffmann S, Camargo FD, Heidel FH, Bystrykh LV, de Haan G, von Eyss B
  Nat Commun 2022, 13(1), 5187 * equal contribution
  
• Locus-specific expression analysis of transposable elements.
  Schwarz R, Koch P, Wilbrandt* J, Hoffmann* S
  Brief Bioinform 2022, 23(1), bbab417 * equal contribution
  

2021

• Life expectancy, family constellation and stress in giant mole-rats ( Fukomys mechowii).
  Begall S, Nappe R, Hohrenk L, Schmidt TC, Burda H, Sahm A, Szafranski K, Dammann P, Henning Y
  Philos Trans R Soc Lond B Biol Sci 2021, 376(1823), 20200207
  
• Favorable outcome of NUTM1-rearranged infant and pediatric B cell precursor acute lymphoblastic leukemia in a collaborative international study.
  Boer JM, Valsecchi MG, Hormann FM, Antić Ž, Zaliova M, Schwab C, Cazzaniga G, Arfeuille C, Cavé H, Attarbaschi A, Strehl S, Escherich G, Imamura T, Ohki K, Grüber TA, Sutton R, Pastorczak A, Lammens T, Lambert F, Li CK, Carrillo de Santa Pau E, Hoffmann S, Möricke A, Harrison CJ, Den Boer ML, De Lorenzo P, Stam RW, Bergmann AK, Pieters R
  Leukemia 2021, 35(10), 2978-82